A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients

about

Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.

P2860

Q47713994-4194DF63-6AD1-4182-8002-BF65402E8D53 Q48278642-46C4C638-8ED3-4286-8B27-A9D17356E1B9

P2860

A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients

Item

http://www.wikidata.org/entity/Q37565596

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A 12-week DBPC dose-finding st ...... se dust mite-allergic patients

@en

A 12-week DBPC dose-finding st ...... e dust mite-allergic patients.

@nl

type

Item

label

A 12-week DBPC dose-finding st ...... se dust mite-allergic patients

@en

A 12-week DBPC dose-finding st ...... e dust mite-allergic patients.

@nl

prefLabel

A 12-week DBPC dose-finding st ...... se dust mite-allergic patients

@en

A 12-week DBPC dose-finding st ...... e dust mite-allergic patients.

@nl

P1476

A 12-week DBPC dose-finding st ...... se dust mite-allergic patients

@en

P2093

C Hüser

http://www.w3.org/2001/XMLSchema#string

E Compalati

http://www.w3.org/2001/XMLSchema#string

J Singh

http://www.w3.org/2001/XMLSchema#string

P Dieterich

http://www.w3.org/2001/XMLSchema#string

R Mösges

http://www.w3.org/2001/XMLSchema#string

S Allekotte

http://www.w3.org/2001/XMLSchema#string

W Lehmacher

http://www.w3.org/2001/XMLSchema#string

P2860

House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies

Sublingual immunotherapy: World Allergy Organization position paper 2013 update.

Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma.

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.

Recommendations for appropriate sublingual immunotherapy clinical trials.

Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais® tablets

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

Update on house dust mite immunotherapy: are more studies needed?

Progress in the development of specific immunotherapies for house dust mite allergies.

P304

77-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ALL.12913

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kija Shah-Hosseini

P577

2016-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27068870

http://www.w3.org/2001/XMLSchema#string

P932

5217067

http://www.w3.org/2001/XMLSchema#string

A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients

about

P2860

P2860

A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932